Evidence Hub

Climate change, pharmaceuticals and prescribing patterns: a scoping review and proposal for the MAMS model for healthcare educators

Mueller K, Allstrom H, Ali N, Leslie S, Modly L, Crane J, Philipsborn R, Smith DJ

Frontiers in public health, 2026

16 participants

Abstract

Background: Healthcare contributes substantially to climate change, and pharmaceuticals account for a meaningful share of this footprint across manufacturing, distribution, prescribing, and disposal. However, climate-health education and prescribing practices are often addressed separately, leaving limited guidance for integrating climate change, pharmaceuticals, and prescribing patterns within a single framework. This scoping review synthesizes evidence on the intersection of these domains, with attention to how these concepts are incorporated into health professions education (HPE) and clinical practice.

Methods: A comprehensive literature search strategy of six databases (PubMed, Embase, CINAHL, ERIC, Health Source: Nursing Academic, and Web of Science) identified peer-reviewed studies published between January 1988 and December 2025 in English or Spanish. Eligible studies addressed climate change in relation to pharmaceutical use or prescribing patterns and included an educational or practice-based component; animal studies, studies without interventions, and non-prescribing studies were excluded. Searches were conducted in December 2023 and updated in April 2025. Data were extracted on study characteristics, clinical domain, educational approach, and directional relationships mapped to the MAMS model dyads (Climate ↔ pharmaceuticals; pharmaceuticals ↔ prescribing patterns; climate ↔ prescribing patterns).

Results: From 4,247 citations, 28 studies met inclusion criteria.…

Read the paper

Related studies

Go deeper in Evidence Hub

Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.

Open this study Sign up free